Park Circle Company’s AbbVie ABBV Stock Holding History

Park Circle Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.3M	Sell	65,895 -6,600	-9%	-$1.46M	13.27%	1
2025 Q4	$16.6M	Hold	72,495	–	–	14.33%	1
2025 Q3	$16.8M	Hold	72,495	–	–	14.06%	1
2025 Q2	$13.5M	Hold	72,495	–	–	11.42%	1
2025 Q1	$15.2M	Hold	72,495	–	–	13.35%	1
2024 Q4	$12.9M	Hold	72,495	–	–	11.48%	1
2024 Q3	$14.3M	Hold	72,495	–	–	12.55%	1
2024 Q2	$12.4M	Hold	72,495	–	–	11.88%	1
2024 Q1	$13.2M	Hold	72,495	–	–	12.09%	1
2023 Q4	$11.2M	Hold	72,495	–	–	10.09%	2
2023 Q3	$10.8M	Hold	72,495	–	–	10.13%	3
2023 Q2	$9.77M	Hold	72,495	–	–	9.15%	3
2023 Q1	$11.6M	Buy	72,495 +3,245	+5%	+$496K	11.16%	2
2022 Q4	$11.2M	Hold	69,250	–	–	10.51%	2
2022 Q3	$9.29M	Hold	69,250	–	–	9.56%	2
2022 Q2	$10.6M	Hold	69,250	–	–	8.71%	2
2022 Q1	$11.2M	Hold	69,250	–	–	9.33%	2
2021 Q4	$9.38M	Hold	69,250	–	–	7.4%	2
2021 Q3	$7.47M	Buy	69,250 +17,300	+33%	+$1.98M	5.67%	4
2021 Q2	$5.85M	Hold	51,950	–	–	4.41%	6
2021 Q1	$5.62M	Buy	51,950 +18,000	+53%	+$1.93M	4.76%	6
2020 Q4	$3.64M	Buy	33,950 +7,000	+26%	+$673K	3.44%	10
2020 Q3	$2.36M	Buy	26,950 +15,450	+134%	+$1.45M	2.61%	12
2020 Q2	$1.13M	Buy	+11,500	New	+$1.01M	1.44%	19
2020 Q1	–	Sell	-20,000	Closed	-$1.77M	–	79
2019 Q4	$1.77M	Buy	+20,000	New	+$1.66M	1.19%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Park Circle Company's ABBV Position: Q1 2026 in Review

Park Circle Company reduced its AbbVie (ABBV) stake by 9.1% in Q1 2026, selling an estimated $1.46M and leaving 65,895 shares worth $14.3M. The position accounts for 13.27% of the portfolio, ranked #1.

Park Circle Company first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $16.8M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Park Circle Company held 65,895 shares of AbbVie worth $14.3M as of Q1 2026.
Park Circle Company sold 6,600 AbbVie shares in Q1 2026, an estimated $1.46M.
AbbVie made up 13.27% of Park Circle Company's portfolio in Q1 2026, its #1 holding.
Park Circle Company first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
Park Circle Company's AbbVie position peaked at $16.8M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Park Circle Company's 13F filing for Q1 2026, filed 14 May 2026.